Dexamethasone Treatment Considerably Reduces the Levels of Some Inflammatory Cytokines, Lactate Dehydrogenase, and C-Reactive Protein in COVID-19 Pneumonia Patients With Pre-existing COPD
Open Access
- 30 October 2024
- journal article
- Published by Maad Rayan Publishing Company in Journal of Kerman University of Medical Sciences
- Vol. 31 (5) , 259-265
Abstract
Background: Dexamethasone is the most widely used corticosteroid for treating COVID-19 pulmonary complications. The effects of dexamethasone on serum inflammatory factors, including C-reactive protein (CRP), lactate dehydrogenase (LDH), and cortisol, were evaluated in COVID-19 pneumonia patients with pre-existing chronic obstructive pulmonary disease (COPD) in this study. Methods: A total of 36 COVID-19 patients with pneumonia who had pre-existing COPD and were critically ill and 56 COVID-19- positive patients without pre-existing COPD were selected. A daily dose of 6–8 mg dexamethasone was administered during the hospitalization period. Some inflammatory markers (TNF-α, IL-10, and IL-6) and the serum levels of cortisol, LDH, and CRP were measured on admission and one week after hospitalization. Results: TNF-α and IL-6 concentrations were significantly reduced and IL-10 significantly increased in all COVID-19 pneumonia patients with or without pre-existing COPD as a result of a daily dose of dexamethasone. Also, a significant reduction in cortisol, CRP, and LDH was observed following dexamethasone administration in all COVID-19 pneumonia patients, with or without preexisting COPD, with no correlation with gender, cigarette or waterpipe smoking, or opium abuse. Conclusion: Our results showed a significant increase in TNF-α, IL-6, IL-10, cortisol, LDH, and CRP and a significant reduction in IL-10 in all critically ill COVID-19 pneumonia patients. Dexamethasone administration significantly reduced cortisol and proinflammatory cytokines and also LDH and CRP as the markers of COVID-19 severity.Keywords
This publication has 56 references indexed in Scilit:
- Corticosteroids in COVID-19 and non-COVID-19 ARDS: a systematic review and meta-analysisIntensive Care Medicine, 2021
- Dexamethasone for the Treatment of Coronavirus Disease (COVID-19): a ReviewSN Comprehensive Clinical Medicine, 2020
- Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection in Children and AdolescentsJAMA Pediatrics, 2020
- Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19)JAMA, 2020
- Deep transfer learning-based automated detection of COVID-19 from lung CT scan slicesApplied Intelligence, 2020
- Immuno-epidemiology and pathophysiology of coronavirus disease 2019 (COVID-19)Journal of Molecular Medicine, 2020
- The cytokine storm and COVID‐19Journal of Medical Virology, 2020
- The impact of COPD and smoking history on the severity of COVID‐19: A systemic review and meta‐analysisJournal of Medical Virology, 2020
- Long-term Systemic Corticosteroid Exposure: A Systematic Literature ReviewClinical Therapeutics, 2017
- Cross-Sectional Association Between Normal-Range Lactate Dehydrogenase, Physical Activity and Cardiovascular Disease Risk ScoreSports Medicine, 2015